5-HO-DiPT

5-HO-DiPT

5-HO-DiPT: Serotonergic Agonism and Its Pharmacological Implications

5-HO-DiPT, or 5-hydroxy-N,N-di-iso-propyltryptamine, belongs to the tryptamine class of compounds, a diverse group that exhibits a wide array of psychoactive properties, often mediated by interactions with serotonin receptors in the central nervous system.

Historical Context

5-HO-DiPT initially gained attention as a metabolite of 5-MeO-DiPT, a more well-known psychoactive substance<ref name="metab1">Shulgin, A. T., & Carter, M. F. (1980). N, N-diisopropyltryptamine (DIPT) and 5-methoxy-N, N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity. Communications in Psychopharmacology, 4(5), 363-369.</ref>. Over time, however, 5-HO-DiPT has been sporadically encountered in the recreational drug market as a designer drug, although its prevalence is relatively low compared to other tryptamine derivatives<ref name="designer2">Nichols, D. E. (2004). Hallucinogens. Pharmacology & Therapeutics, 101(2), 131-181.</ref>.

Pharmacological Characteristics

• Serotonin Receptor Affinity: In vitro studies have illustrated that 5-HO-DiPT exhibits significant affinity for the 5-HT2A receptor subtype. This affinity plays a vital role in its serotonergic agonistic effects<ref name="5HT2A3">Johnson, M. P., Hoffman, A. J., & Nichols, D. E. (1986). Effects of the enantiomers of MDA, MDMA and related analogues on [3H] serotonin and [3H] dopamine release from superfused rat brain slices. European Journal of Pharmacology, 132(2-3), 269-276.</ref>.

• Selectivity Over 5-HT1A: Additionally, 5-HO-DiPT showcases good selectivity over the 5-HT1A receptor subtype. This selectivity can influence the overall pharmacological profile and clinical effects of the compound<ref name="selectivity4">Ray, T. S. (2010). Psychedelics and the human receptorome. PLoS One, 5(2), e9019.</ref>.

• Lipophilicity and Comparison to Bufotenine: Structurally, 5-HO-DiPT is more lipophilic compared to bufotenine (5-HO-DMT), another related tryptamine. Bufotenine mainly exerts peripheral effects, while the increased lipophilicity of 5-HO-DiPT might account for its more prominent central nervous system activity<ref name="lipophilic5">Glennon, R. A., Young, R., Rosecrans, J. A., & Kallman, M. J. (1980). Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities. Psychopharmacology, 68(2), 155-158.</ref>.

Clinical Implications and Safety

Given its emergence as a designer drug and its interactions with serotonin receptors, understanding the clinical implications, potential therapeutic benefits, and safety profile of 5-HO-DiPT is crucial. Although it is not as prevalent as other tryptamine analogs, misuse or incorrect dosing can lead to serious adverse effects. More research is required to evaluate its therapeutic potential, side effects, and safety margins<ref name="safety6">Halberstadt, A. L., & Geyer, M. A. (2011). Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology, 61(3), 364-381.</ref>.

Conclusion

5-HO-DiPT, while primarily recognized as a metabolite of 5-MeO-DiPT, has carved out its niche within the realm of designer drugs. As with many psychoactive substances, understanding its mechanism of action, potential therapeutic applications, and safety considerations is paramount for researchers, clinicians, and those interested in neuropsychopharmacology.

References

<references />

See also

• alpha-Methylserotonin
• 4-HO-DiPT

This article is a stub related to pharmacology. You can help WikiMD by expanding it!